ID   CC-8
AC   CVCL_DF78
SY   CC8
DR   cancercelllines; CVCL_DF78
DR   GEO; GSM226734
DR   GEO; GSM226868
DR   Progenetix; CVCL_DF78
DR   Wikidata; Q54808708
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Doubling time: 55 +- 7 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
RX   PubMed=10554043;
RA   Koopman L.A., Szuhai K., van Eendenburg J.D.H., Bezrookove V.,
RA   Kenter G.G., Schuuring E.M.D., Tanke H.J., Fleuren G.J.;
RT   "Recurrent integration of human papillomaviruses 16, 45, and 67 near
RT   translocation breakpoints in new cervical cancer cell lines.";
RL   Cancer Res. 59:5615-5624(1999).
//
RX   PubMed=17311676; DOI=10.1186/1471-2164-8-53; PMCID=PMC1805756;
RA   Kloth J.N., Oosting J., van Wezel T., Szuhai K., Knijnenburg J.,
RA   Gorter A., Kenter G.G., Fleuren G.J., Jordanova E.S.;
RT   "Combined array-comparative genomic hybridization and
RT   single-nucleotide polymorphism-loss of heterozygosity analysis reveals
RT   complex genetic alterations in cervical cancer.";
RL   BMC Genomics 8:53.1-53.13(2007).
//